ERBB2 and colorectal carcinoma: For example, LINC00426 was found to be upregulated in TNBC, non-TNBC, and HER2-positive breast cancer patients [63] and downregulated in patients with colorectal carcinoma, non-small-cell lung carcinoma [64], and lung squamous cell carcinoma [65].